Inflammatory Marker | Measurement | Tertile | Univariate1 | Multivariable2 | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | 2 | 3 | F | p | Age | A | B or C3 | |||||
F | p | F | p | F | p | |||||||
CRP | mg/ml | ≤ 7.0 | 8–13 | > 14 | ||||||||
n | 44 | 31 | 37 | |||||||||
QTBAZ | ms | 417.4 ± 22.9 | 425.5 ± 18.4 | 428.0 ± 24.2 | 2.552 | 0.083 | 2.675 | 0.073 | 4.078 | 0.020*† | 2.497 | 0.087 |
QTFHS | ms | 410.9 ± 19.2 | 414.5 ± 17.0 | 412.8 ± 17.6 | 0.362 | 0.697 | 0.375 | 0.688 | 1.760 | 1.155 | 0.177 | 0.319 |
IL-6 | pg/ml | ≤ 6.3 | 6.31–37.23 | > 37.24 | ||||||||
n | 38 | 37 | 37 | |||||||||
QTBAZ | ms | 417.0 ± 20.7 | 426.3 ± 21.4 | 426.3 ± 24.6 | 2.214 | 0.114 | 0.954 | 0.388 | 0.972 | 0.382 | 0.615 | 0.543 |
QTFHS | ms | 409.5 ± 16.0 | 415.1 ± 17.5 | 413.1 ± 20.2 | 0.942 | 0.393 | 0.892 | 0.413 | 0.505 | 0.605 | 0.245 | 0.783 |
TNF-α | pg/ml | ≤ 6.14 | 6.15–23.99 | > 24.0 | ||||||||
n | 38 | 37 | 37 | |||||||||
QTBAZ | ms | 419.1 ± 23.5 | 421.4 ± 20.8 | 429.2 ± 22.5 | 2.109 | 0.126 | 1.174 | 0.313 | 0.883 | 0.417 | 1.320 | 0.271 |
QTFHS | ms | 408.6 ± 15.7 | 410.8 ± 17.3 | 418.4 ± 19.7 | 3.153 | 0.047† | 1.823 | 0.167 | 1.381 | 0.256 | 1.570 | 0.213 |
IL-1α | pg/ml | 0.0 | 0.01–9.45 | > 9.46 | ||||||||
n | 41 | 34 | 37 | |||||||||
QTBAZ | ms | 422.9 ± 27.4 | 419.1 ± 18.1 | 427.1 ± 19.9 | 1.123 | 0.329 | 1.036 | 0.358 | 1.214 | 0.301 | 0.860 | 0.426 |
QTFHS | ms | 410.8 ± 17.9 | 410.1 ± 16.7 | 416.8 ± 18.9 | 1.549 | 0.217 | 0.248 | 0.781 | 1.141 | 0.323 | 0.907 | 0.407 |
IL-1β | pg/ml | ≤ 0.45 | 0.46–3.51 | > 3.52 | ||||||||
n | 38 | 37 | 37 | |||||||||
QTBAZ | ms | 418.4 ± 26.2 | 423.9 ± 21.2 | 427.2 ± 19.2 | 1.460 | 0.237 | 0.860 | 0.426 | 0.507 | 0.604 | 0.838 | 0.435 |
QTFHS | ms | 408.2 ± 17.1 | 411.7 ± 18.0 | 412.5 ± 18.0 | 2.806 | 0.065 | 2.004 | 0.140 | 1.584 | 0.210 | 1.800 | 0.170 |
IL-10 | pg/ml | 0.0 | 0.01–2.0 | > 2.01 | ||||||||
n | 40 | 35 | 37 | |||||||||
QTBAZ | ms | 413.4 ± 20.8 | 429.8 ± 23.7 | 427.4 ± 19.9 | 6.506 | 0.002*† | 5.555 | 0.005*† | 3.255 | 0.042*† | 4.212 | 0.017*† |
QTFHS | ms | 405.6 ± 14.9 | 415.6 ± 18.2 | 417.1 ± 19.0 | 4.989 | 0.008*† | 3.976 | 0.022*† | 2.498 | 0.087 | 3.344 | 0.039† |
Values in bold face are the cytokine concentration in each tertile.
↵1 Univariate analysis performed using 1-way ANOVA with Tukey posthoc test.
↵2 Multivariable analysis performed with adjustments for age alone: model A (age, sex, presence of ischemic heart disease, and hydroxychloroquine use), and
↵3 either model B (age, sex, β blocker use, and hydroxychloroquine use for QTBAZ) or model C (age, sex, presence of hypercholesterolemia, and hydroxychloroquine use for QTFHS), with least significant difference posthoc test. Posthoc significance p < 0.05.
↵* tertile 1 vs 2,
↵† tertile 1 vs 3. QTc: corrected QT; CRP: C-reactive protein; QTBAZ: QT corrected using the Bazett formula; QTFHS: QT corrected using the Framingham Heart Study formula; IL: interleukin; TNF-α: tumor necrosis factor-α.